Adage Capital Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.7M Sell
325,391
-321,880
-50% -$22.5M 0.04% 416
2025
Q1
$47.6M Buy
647,271
+293,833
+83% +$21.6M 0.09% 235
2024
Q4
$23.2M Buy
+353,438
New +$23.2M 0.04% 406
2024
Q3
Sell
-346,468
Closed -$27M 877
2024
Q2
$27M Buy
+346,468
New +$27M 0.05% 362
2023
Q4
Sell
-1,439,929
Closed -$97.5M 857
2023
Q3
$97.5M Buy
1,439,929
+426,822
+42% +$28.9M 0.22% 111
2023
Q2
$72.5M Buy
1,013,107
+713,107
+238% +$51M 0.16% 148
2023
Q1
$20.8M Sell
300,000
-976,725
-77% -$67.8M 0.05% 403
2022
Q4
$86.6M Buy
1,276,725
+802,021
+169% +$54.4M 0.21% 119
2022
Q3
$26M Sell
474,704
-47,256
-9% -$2.59M 0.06% 337
2022
Q2
$34.5M Sell
521,960
-188,040
-26% -$12.4M 0.08% 269
2022
Q1
$47.1M Sell
710,000
-40,000
-5% -$2.65M 0.09% 228
2021
Q4
$43.7M Sell
750,000
-2,063,663
-73% -$120M 0.08% 257
2021
Q3
$169M Buy
+2,813,663
New +$169M 0.33% 59
2020
Q4
Sell
-675,000
Closed -$37M 811
2020
Q3
$37M Buy
675,000
+500,000
+286% +$27.4M 0.09% 229
2020
Q2
$9.26M Sell
175,000
-375,000
-68% -$19.8M 0.02% 536
2020
Q1
$24.6M Buy
550,000
+150,000
+38% +$6.7M 0.07% 280
2019
Q4
$19.9M Sell
400,000
-100,000
-20% -$4.99M 0.05% 388
2019
Q3
$22.3M Buy
+500,000
New +$22.3M 0.05% 342
2019
Q1
Sell
-500,000
Closed -$19M 696
2018
Q4
$19M Hold
500,000
0.05% 347
2018
Q3
$19.8M Sell
500,000
-850,000
-63% -$33.6M 0.04% 404
2018
Q2
$47.4M Sell
1,350,000
-600,000
-31% -$21.1M 0.11% 232
2018
Q1
$68.2M Sell
1,950,000
-150,000
-7% -$5.25M 0.16% 168
2017
Q4
$72.9M Buy
2,100,000
+650,000
+45% +$22.6M 0.16% 150
2017
Q3
$49.1M Buy
+1,450,000
New +$49.1M 0.12% 224
2017
Q2
Sell
-100,000
Closed -$3.11M 705
2017
Q1
$3.11M Sell
100,000
-488,731
-83% -$15.2M 0.01% 643
2016
Q4
$16.1M Sell
588,731
-11,269
-2% -$308K 0.04% 420
2016
Q3
$19.7M Buy
+600,000
New +$19.7M 0.05% 387
2016
Q1
Sell
-20,000
Closed -$679K 688
2015
Q4
$679K Buy
+20,000
New +$679K ﹤0.01% 668
2013
Q4
Sell
-800,000
Closed -$20.8M 684
2013
Q3
$20.8M Buy
+800,000
New +$20.8M 0.06% 364